Concert Pharmaceuticals
Latest round
- Series C
Last raised
- Apr 2008
Total raised
- $95M
Investors
- 12
About Concert Pharmaceuticals
Concert Pharmaceuticals, Inc.Founded in 2006 and headquartered in Lexington, US, Concert Pharmaceuticals, Inc. is engaged in creating novel pharmaceutical solutions.00 mn from Sun Pharmaceutical Industries Limited.Concert Pharmaceuticals focuses on developing innovative therapeutics that utilize its proprietary DCE Platform (Deuterated Chemical Entity) to create deuterated compounds. These products aim to improve efficacy and safety and reduce side effects of existing drugs, particularly in psychiatry, dermatology, and inflammatory diseases, ultimately enhancing patient outcomes and adherence.S.03 mn.00 mn to advance early clinical efficacy studies specifically targeting HIV-positive patients. The company is focused on expanding its product pipeline with upcoming launches designed to meet critical therapeutic demands. Additionally, Concert is seeking to penetrate further into international markets, particularly in Europe and Asia, in the coming years.
Who invested in Concert Pharmaceuticals
12 investors across 3 rounds
See all investors in Concert Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Concert Pharmaceuticals
Who invested in Concert Pharmaceuticals?
Concert Pharmaceuticals has 12 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Concert Pharmaceuticals raised?
Concert Pharmaceuticals has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Concert Pharmaceuticals last raise money?
Concert Pharmaceuticals's most recent round on record is a Series C, in Apr 2008.
What does Concert Pharmaceuticals do?
Concert Pharmaceuticals is a pharmaceuticals company.
Where is Concert Pharmaceuticals headquartered?
Concert Pharmaceuticals is headquartered in Lexington, US.
Which VCs invest in companies like Concert Pharmaceuticals?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Concert Pharmaceuticals's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series C
Raising like Concert Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.